WAS/WASL interacting protein family, member 2 (WIPF2) expression in breast carcinomas (2011)
- Authors:
- USP affiliated authors: CARLOTTI JUNIOR, CARLOS GILBERTO - FMRP ; TIÉZZI, DANIEL GUIMARÃES - FMRP ; TIRAPELLI, DANIELA PRETTI DA CUNHA - FMRP ; SILVA, ALFREDO RIBEIRO DA - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS MAMÁRIAS; CARCINOMA; PROTEÍNAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the American Association for Cancer Research (AACR)
-
ABNT
TIEZZI, Daniel Guimarães et al. WAS/WASL interacting protein family, member 2 (WIPF2) expression in breast carcinomas. 2011, Anais.. Orlando: AACR, 2011. . Acesso em: 29 dez. 2025. -
APA
Tiezzi, D. G., Tiezzi, D. G., Pimentel, F. F., Antonio, H. M. R., Sicchieri, R., Tirapelli, D. P. C., et al. (2011). WAS/WASL interacting protein family, member 2 (WIPF2) expression in breast carcinomas. In Abstracts. Orlando: AACR. -
NLM
Tiezzi DG, Tiezzi DG, Pimentel FF, Antonio HMR, Sicchieri R, Tirapelli DPC, Oliveira FM, Marana HRC, Silva AR da, Bosland MC, Andrade JM, Carlotti Júnior CG. WAS/WASL interacting protein family, member 2 (WIPF2) expression in breast carcinomas. Abstracts. 2011 ;[citado 2025 dez. 29 ] -
Vancouver
Tiezzi DG, Tiezzi DG, Pimentel FF, Antonio HMR, Sicchieri R, Tirapelli DPC, Oliveira FM, Marana HRC, Silva AR da, Bosland MC, Andrade JM, Carlotti Júnior CG. WAS/WASL interacting protein family, member 2 (WIPF2) expression in breast carcinomas. Abstracts. 2011 ;[citado 2025 dez. 29 ] - Integrated genomic and molecular characterization of cervical cancer
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Qualitative analysis of ncRNAs in metastatic breast tumor
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
